Literature DB >> 16059489

Endocannabinoids and their implications for epilepsy.

Bradley E Alger1.   

Abstract

This review covers the main features of a newly discovered intercellular signaling system in which endogenous ligands of the brain's cannabinoid receptors, or endocannabinoids, serve as retrograde messengers that enable a cell to control the strength of its own synaptic inputs. Endocannabinoids are released by bursts of action potentials, including events resembling interictal spikes, and probably by seizures as well. Activation of cannabinoid receptors has been implicated in neuroprotection against excitotoxicity and can help explain the anticonvulsant properties of cannabinoids that have been known since antiquity.

Entities:  

Year:  2004        PMID: 16059489      PMCID: PMC1176361          DOI: 10.1111/j.1535-7597.2004.04501.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN: 1535-7511            Impact factor:   7.500


  43 in total

1.  CB1 cannabinoid receptors and on-demand defense against excitotoxicity.

Authors:  Giovanni Marsicano; Sharon Goodenough; Krisztina Monory; Heike Hermann; Matthias Eder; Astrid Cannich; Shahnaz C Azad; Maria Grazia Cascio; Silvia Ortega Gutiérrez; Mario van der Stelt; Maria Luz López-Rodriguez; Emilio Casanova; Günther Schütz; Walter Zieglgänsberger; Vincenzo Di Marzo; Christian Behl; Beat Lutz
Journal:  Science       Date:  2003-10-03       Impact factor: 47.728

2.  Presynaptic factors in the regulation of DSI expression in hippocampus.

Authors:  Namita Varma; Darrin Brager; Wade Morishita; Robert A Lenz; Barry London; Bradley Alger
Journal:  Neuropharmacology       Date:  2002-09       Impact factor: 5.250

Review 3.  The effects of cannabinoids on the brain.

Authors:  A Ameri
Journal:  Prog Neurobiol       Date:  1999-07       Impact factor: 11.685

Review 4.  The cannabinoid receptors.

Authors:  Allyn C Howlett
Journal:  Prostaglandins Other Lipid Mediat       Date:  2002-08       Impact factor: 3.072

Review 5.  Unveiling the functions of presynaptic metabotropic glutamate receptors in the central nervous system.

Authors:  D D Schoepp
Journal:  J Pharmacol Exp Ther       Date:  2001-10       Impact factor: 4.030

6.  Presynaptic specificity of endocannabinoid signaling in the hippocampus.

Authors:  R I Wilson; G Kunos; R A Nicoll
Journal:  Neuron       Date:  2001-08-16       Impact factor: 17.173

7.  Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus.

Authors:  Jimok Kim; Masako Isokawa; Catherine Ledent; Bradley E Alger
Journal:  J Neurosci       Date:  2002-12-01       Impact factor: 6.167

8.  Increased seizure susceptibility and proconvulsant activity of anandamide in mice lacking fatty acid amide hydrolase.

Authors:  Angela B Clement; E Gregory Hawkins; Aron H Lichtman; Benjamin F Cravatt
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

9.  Brain monoglyceride lipase participating in endocannabinoid inactivation.

Authors:  T P Dinh; D Carpenter; F M Leslie; T F Freund; I Katona; S L Sensi; S Kathuria; D Piomelli
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-22       Impact factor: 11.205

10.  Postsynaptic spike firing reduces synaptic GABAA responses in hippocampal pyramidal cells.

Authors:  T A Pitler; B E Alger
Journal:  J Neurosci       Date:  1992-10       Impact factor: 6.167

View more
  19 in total

1.  Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain.

Authors:  Katherine W Sayers; Peter T Nguyen; Robert E Blair; Laura J Sim-Selley; Robert J DeLorenzo
Journal:  Epilepsia       Date:  2012-04-17       Impact factor: 5.864

2.  Endocannabinoids: a critical regulator of activity in the developing brain.

Authors:  Douglas A Coulter
Journal:  Epilepsy Curr       Date:  2006 Jan-Feb       Impact factor: 7.500

3.  Seedling Chloroplast Responses Induced by N-Linolenoylethanolamine Require Intact G-Protein Complexes.

Authors:  Chengshi Yan; Ashley E Cannon; Justin Watkins; Jantana Keereetaweep; Bibi Rafeiza Khan; Alan M Jones; Elison B Blancaflor; Rajeev K Azad; Kent D Chapman
Journal:  Plant Physiol       Date:  2020-07-14       Impact factor: 8.340

4.  Selective reduction of cholecystokinin-positive basket cell innervation in a model of temporal lobe epilepsy.

Authors:  Megan S Wyeth; Nianhui Zhang; Istvan Mody; Carolyn R Houser
Journal:  J Neurosci       Date:  2010-06-30       Impact factor: 6.167

Review 5.  Endogenous cannabinoid signaling at inhibitory interneurons.

Authors:  Thomas J Younts; Pablo E Castillo
Journal:  Curr Opin Neurobiol       Date:  2013-12-28       Impact factor: 6.627

Review 6.  Layer 3 Excitatory and Inhibitory Circuitry in the Prefrontal Cortex: Developmental Trajectories and Alterations in Schizophrenia.

Authors:  Gil D Hoftman; Dibyadeep Datta; David A Lewis
Journal:  Biol Psychiatry       Date:  2016-06-04       Impact factor: 13.382

Review 7.  Marijuana, Spice 'herbal high', and early neural development: implications for rescheduling and legalization.

Authors:  Delphine Psychoyos; K Yaragudri Vinod
Journal:  Drug Test Anal       Date:  2012-08-13       Impact factor: 3.345

8.  Pharmacological enhancement of endocannabinoid signaling reduces the cholinergic toxicity of diisopropylfluorophosphate.

Authors:  Anuradha Nallapaneni; Jing Liu; Subramanya Karanth; Carey Pope
Journal:  Neurotoxicology       Date:  2008-08-13       Impact factor: 4.294

9.  Evaluation of interactions between cannabinoid compounds and diazepam in electroshock-induced seizure model in mice.

Authors:  Nima Naderi; Farzad Aziz Ahari; Bijan Shafaghi; Azadeh Hosseini Najarkolaei; Fereshteh Motamedi
Journal:  J Neural Transm (Vienna)       Date:  2008-06-25       Impact factor: 3.575

10.  CA1 pyramidal cell theta-burst firing triggers endocannabinoid-mediated long-term depression at both somatic and dendritic inhibitory synapses.

Authors:  Thomas J Younts; Vivien Chevaleyre; Pablo E Castillo
Journal:  J Neurosci       Date:  2013-08-21       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.